Delivery Order SPE2DB24D2100-SPE2DB24FBDLA
Award Date
9/9/24
Potential Completion Date
9/10/24
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 11, 2024, with a ceiling value of $1,383.00. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 12, 2024. This contract is not designated...
This federal contract award is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp's Corporate Office Division. The award, valued at $6,092.71, is a firm fixed price delivery order contract with an ultimate completion date of April 24, 2024. This contract is not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $2,571.11, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 15, 2024. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, for delivering a wide range of...
This federal contract award is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,052.01 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract has a total ceiling value of $1,894.56 and an ultimate completion date of October 8, 2024. It is a firm-fixed-price contract, without any set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, will be the prime contractor responsible for delivering the required medical...
This federal contract award, valued at $1,270.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 13, 2024. The contract was awarded on December 12, 2024 and was not set aside for any specific business category....
This federal contract award to Amerisourcebergen Drug Corp is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, under a Delivery Order valued at $1,761.36. The contract was awarded by the Defense Logistics Agency (DLA), a Defense agency, and has a completion date of February 2, 2023. Amerisourcebergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026,...
This federal contract award by the Defense Logistics Agency (DLA) is for the delivery of 4,564,911,315 units of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The $1,221.33 firm-fixed-price contract has a completion date of June 17, 2024 and was awarded on June 14, 2024 to Amerisourcebergen Drug Corp's Corporate Office division.
Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract with the DLA Troop Support Medical as the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $3,882.35 for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML. The contract was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of April 3, 2024.
The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML. The $2,723.50 firm fixed-price contract has a completion date of November 1, 2024 and was awarded on October 31, 2024. This contract is not designated as a set-aside and is likely part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...